Angina Clinical Trial
Official title:
A Prospective, Multicenter, Single Arm Study of Transmyocardial Revascularization (TMR) Plus Bone Marrow Aspirate Concentrated (BMAC) Using the Cardiogenesis PHOENIX Combination Handpiece Delivery System
The purpose of this study is to determine the safety of injecting autologous bone marrow concentrate with laser transmyocardial revascularization (TMR) for treatment of angina which cannot be treated by direct coronary intervention.
Recently published information suggests the delivery of concentrated autologous bone marrow, in combination with transmyocardial revascularization (TMR) may provide synergistic effects for the reduction of angina in patients who are not treatable with conventional coronary artery bypass or percutaneous coronary intervention. This safety and feasibility study is intended to confirm the work previously done at one hospital in a larger, multicenter setting. Patients who are candidates for TMR will be asked to participate. ;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
| Withdrawn |
NCT03134105 -
A Wearable EducAtional Intervention to REduce Angina
|
N/A | |
| Completed |
NCT02832115 -
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
|
Phase 4 | |
| Completed |
NCT02265796 -
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
|
Phase 2 | |
| Terminated |
NCT00221182 -
Stem Cell Study for Patients With Heart Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT01721096 -
XIENCE PRIME Japan Post-Marketing Surveillance (PMS)
|
||
| Recruiting |
NCT01214499 -
Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina
|
Phase 2 | |
| Withdrawn |
NCT00774891 -
Comparison Of Left Ventricular Volume And Wall Stress With Dobutamine And Exercise Echocardiography
|
N/A | |
| Completed |
NCT02707783 -
Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina
|
||
| Completed |
NCT02065102 -
Optical Coherence Tomography to Improve Clinical Outcomes During Coronary Angioplasty
|
N/A | |
| Completed |
NCT00946725 -
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
|
Phase 1 | |
| Recruiting |
NCT02439541 -
Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
| Withdrawn |
NCT00657514 -
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease
|
Phase 4 | |
| Recruiting |
NCT01361659 -
Shockwave Treatment for Advanced Angina in Maastricht
|
N/A | |
| Recruiting |
NCT05786417 -
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
|
Phase 4 | |
| Withdrawn |
NCT02507050 -
Ivabradine and Post-revascularisation Microcirculatory Dysfunction
|
Phase 4 | |
| Active, not recruiting |
NCT02468960 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)
|
N/A | |
| Completed |
NCT01086228 -
XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan
|
N/A | |
| Completed |
NCT00824005 -
Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)
|
Phase 2 |